Is Perspective Therapeutics, Inc. (CATX) a Buy, Sell, or Hold?
AMEX : CATX
Perspective Therapeutics, Inc.
$2.99 USD
$0.04 (1.36%)
- Volume
- 849.82K
- Average Volume
- 1.86M
- Market Capitalization
- $230.98M
- P/E Ratio
- -0.11
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $6.16
- Year Low
- $1.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.75
Insider Activity Summary (Last 12 Months)
Insiders Buying
26
Insiders Selling
0
Amount of Insider Selling
-$
CATX Insider Buying/Selling by Quarter
CATX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Martinez Maria E | director | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Morich Frank | director | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Williamson Robert F III | director | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| HENSON HEIDI | director | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Woods Lori A | director | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Spoor Johan M. | director, officer: Chief Executive Officer | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Hunt Jonathan Robert | officer: Chief Accounting Officer | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Puhlmann Markus | officer: Chief Medical Officer | 2026-03-02 | A-Award | 5.35 | 2026-03-04 |
| Hunt Jonathan Robert | officer: Chief Accounting Officer | 2025-11-13 | P-Purchase | 2.0268 | 2025-11-17 |
| Williamson Robert F III | director | 2025-11-12 | P-Purchase | 2.1 | 2025-11-14 |
| Sendek Joel | officer: Chief Financial Officer | 2025-09-04 | A-Award | 3.54 | 2025-09-05 |
| Sendek Joel | 2025-09-04 | 0 | 2025-09-05 | ||
| Martinez Maria E | director | 2025-09-03 | A-Award | 3.38 | 2025-09-05 |
| Martinez Maria E | 2025-09-03 | 0 | 2025-09-05 | ||
| Spoor Johan M. | director, officer: Chief Executive Officer | 2025-03-28 | P-Purchase | 2.2421 | 2025-04-01 |
| Spoor Johan M. | director, officer: Chief Executive Officer | 2025-03-28 | P-Purchase | 2.2125 | 2025-04-01 |
| Williamson Robert F III | director | 2025-03-31 | P-Purchase | 2.1438 | 2025-04-01 |
| Williamson Robert F III | director | 2025-03-28 | P-Purchase | 2.27 | 2025-04-01 |
| Graham Juan | officer: Chief Financial Officer | 2025-03-28 | P-Purchase | 2.2484 | 2025-04-01 |
| Woods Lori A | director | 2025-03-31 | P-Purchase | 2.1299 | 2025-04-01 |
| Puhlmann Markus | officer: Chief Medical Officer | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| Hunt Jonathan Robert | officer: Chief Accounting Officer | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| Spoor Johan M. | director, officer: Chief Executive Officer | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| HENSON HEIDI | director | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| Williamson Robert F III | director | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| Morich Frank | director | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| Woods Lori A | director | 2025-03-03 | A-Award | 2.46 | 2025-03-05 |
| Graham Juan | officer: Chief Financial Officer | 2025-01-06 | A-Award | 3.53 | 2025-01-07 |
| Graham Juan | officer: Chief Financial Officer | 2025-01-06 | 0 | 2025-01-07 | |
| HENSON HEIDI | director | 2024-12-04 | P-Purchase | 3.85 | 2024-12-06 |
| Spoor Johan M. | director, officer: CEO | 2024-12-04 | P-Purchase | 3.7665 | 2024-12-04 |
| Williamson Robert F III | 2024-11-25 | 0 | 2024-12-04 | ||
| Spoor Johan M. | 2024-11-25 | 0 | 2024-12-04 | ||
| Williamson Robert F III | director | 2024-11-25 | P-Purchase | 3.67 | 2024-11-27 |
| Williamson Robert F III | director | 2024-11-25 | P-Purchase | 3.6199 | 2024-11-27 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-11-25 | P-Purchase | 3.88 | 2024-11-27 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-11-25 | P-Purchase | 3.6 | 2024-11-27 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-11-25 | P-Purchase | 3.94 | 2024-11-27 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-11-25 | P-Purchase | 3.55 | 2024-11-27 |
| Spoor Johan M. | director, officer: CEO | 2024-11-25 | P-Purchase | 3.784 | 2024-11-26 |
| Spoor Johan M. | director, officer: CEO | 2024-11-25 | P-Purchase | 3.8 | 2024-11-26 |
| Spoor Johan M. | director, officer: CEO | 2024-11-25 | P-Purchase | 3.8 | 2024-11-26 |
| Austin Mark John | officer: VP Finance/Prin Fin&Acct Offic | 2024-07-17 | A-Award | 11.96 | 2024-07-19 |
| Williamson Robert F III | director | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| Morich Frank | director | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| Woods Lori A | director | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| HENSON HEIDI | director | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| Spoor Johan M. | director, officer: CEO | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| Puhlmann Markus | officer: Chief Medical Officer | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-06-20 | A-Award | 10.65 | 2024-06-24 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-06-17 | P-Purchase | 9.815 | 2024-06-18 |
| Woods Lori A | director | 2024-06-14 | P-Purchase | 10.8 | 2024-06-18 |
| Woods Lori A | director | 2024-06-14 | P-Purchase | 10.9 | 2024-06-18 |
| Spoor Johan M. | director, officer: CEO | 2024-06-13 | P-Purchase | 1.1743 | 2024-06-13 |
| Woods Lori A | 2024-06-03 | 0 | 2024-06-05 | ||
| Woods Lori A | director | 2024-06-03 | P-Purchase | 1.4598 | 2024-06-04 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-05-31 | P-Purchase | 1.4 | 2024-06-03 |
| Hunt Jonathan Robert | officer: Chief Financial Officer | 2024-05-31 | P-Purchase | 1.3999 | 2024-06-03 |
| Williamson Robert F III | director | 2024-05-31 | P-Purchase | 1.38 | 2024-06-03 |
| Williamson Robert F III | director | 2024-05-29 | P-Purchase | 1.34 | 2024-05-30 |
| Williamson Robert F III | director | 2024-05-29 | P-Purchase | 1.32 | 2024-05-30 |
| Austin Mark John | officer: VP Finance/Prin Fin&Acct Offic | 2024-04-23 | M-Exempt | 0.36 | 2024-04-24 |
| Austin Mark John | officer: VP Finance/Prin Fin&Acct Offic | 2024-04-23 | M-Exempt | 0.36 | 2024-04-24 |
| Lantheus Alpha Therapy, LLC | 10 percent owner | 2024-03-06 | P-Purchase | 0.95 | 2024-03-08 |
| Williamson Robert F III | director | 2024-01-30 | P-Purchase | 0.7 | 2024-02-01 |
| Williamson Robert F III | director | 2024-01-30 | P-Purchase | 0.72 | 2024-02-01 |
| Williamson Robert F III | director | 2024-01-30 | P-Purchase | 0.71 | 2024-02-01 |
| Williamson Robert F III | director | 2024-01-30 | P-Purchase | 0.71 | 2024-02-01 |
| Williamson Robert F III | director | 2024-01-30 | P-Purchase | 0.71 | 2024-02-01 |
| Lantheus Alpha Therapy, LLC | 10 percent owner | 2024-01-22 | 0 | 2024-02-01 | |
| Williamson Robert F III | director | 2024-01-29 | P-Purchase | 0.64 | 2024-01-30 |
| Williamson Robert F III | director | 2024-01-29 | P-Purchase | 0.64 | 2024-01-30 |
| Williamson Robert F III | director | 2024-01-26 | P-Purchase | 0.54 | 2024-01-30 |
| Williamson Robert F III | director | 2024-01-26 | P-Purchase | 0.55 | 2024-01-30 |
| Williamson Robert F III | director | 2024-01-26 | P-Purchase | 0.59 | 2024-01-30 |
| Williamson Robert F III | director | 2024-01-26 | P-Purchase | 0.61 | 2024-01-30 |
| Williamson Robert F III | director | 2024-01-26 | P-Purchase | 0.61 | 2024-01-30 |
| Puhlmann Markus | officer: Chief Medical Officer | 2024-01-24 | P-Purchase | 0.4996 | 2024-01-26 |
| Williamson Robert F III | director | 2024-01-25 | P-Purchase | 0.49 | 2024-01-26 |
| Williamson Robert F III | director | 2024-01-24 | P-Purchase | 0.49 | 2024-01-26 |